Literature DB >> 14662847

CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.

Abigail Clatza1, Laura C Bonifaz, Dario A A Vignali, José Moreno.   

Abstract

Ligation of CD40 on B cells increases their ability to present Ag and to activate MHC class II (MHC-II)-restricted T cells. How this occurs is not entirely clear. In this study we demonstrate that CD40 ligation on Ag-presenting B cells (APC) for a short period between 30 min and 3 h has a rapid, augmenting effect on the ability of a B cell line and normal B cells to activate T cells. This is not due to alterations in Ag processing or to an increase in surface expression of CD80, CD86, ICAM-1, or MHC-II. This effect is particularly evident with naive, resting T lymphocytes and appears to be more pronounced under limiting Ag concentrations. Shortly after CD40 ligation on a B cell line, MHC-II and CD80 progressively accumulated in cholesterol-enriched microdomains on the cell surface, which correlated with an initial enhancement in their Ag presentation ability. Moreover, CD40 ligation induced a second, late, more sustained enhancement of Ag presentation, which correlates with a significant increase in CD80 expression by APC. Thus, CD40 signaling enhances the efficiency with which APC activate T cells by at least two related, but distinct, mechanisms: an early stage characterized by aggregation of MHC-II and CD80 clusters, and a late stage in which a significant increase in CD80 expression is observed. These results raise the possibility that one important role of CD40 is to contribute to the formation of the immunological synapse on the APC side.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662847     DOI: 10.4049/jimmunol.171.12.6478

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Characterization of plasmacytoid dendritic cells in bone marrow of pig-tailed macaques.

Authors:  R Keith Reeves; Patricia N Fultz
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

Review 2.  MHC class II association with lipid rafts on the antigen presenting cell surface.

Authors:  Howard A Anderson; Paul A Roche
Journal:  Biochim Biophys Acta       Date:  2014-09-28

3.  RAFTsomes containing epitope-MHC-II complexes mediated CD4+ T cell activation and antigen-specific immune responses.

Authors:  Qian Ding; Jian Chen; Xiaohui Wei; Wenqiang Sun; Junhua Mai; Yanzhu Yang; Yuhong Xu
Journal:  Pharm Res       Date:  2012-08-10       Impact factor: 4.200

Review 4.  The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance.

Authors:  Renee B Chang; Gregory L Beatty
Journal:  J Leukoc Biol       Date:  2020-04-09       Impact factor: 4.962

5.  Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells.

Authors:  Wei Jiang; Michael M Lederman; Clifford V Harding; Scott F Sieg
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

6.  Expression of activated molecules on CD5(+)B lymphocytes in autoimmune hemolytic anemia.

Authors:  Hongli Zhu; Wenyan Xu; Hong Liu; Huaquan Wang; Rong Fu; Yuhong Wu; Wen Qu; Guojin Wang; Jing Guan; Jia Song; Limin Xing; Zonghong Shao
Journal:  Int J Hematol       Date:  2016-03-11       Impact factor: 2.490

7.  Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer.

Authors:  Yong Li; Xiaosong Li; Austin Doughty; Connor West; Lu Wang; Feifan Zhou; Robert E Nordquist; Wei R Chen
Journal:  Nanomedicine       Date:  2019-03-04       Impact factor: 5.307

8.  Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours.

Authors:  Aslan Mansurov; Jun Ishihara; Peyman Hosseinchi; Lambert Potin; Tiffany M Marchell; Ako Ishihara; John-Michael Williford; Aaron T Alpar; Michal M Raczy; Laura T Gray; Melody A Swartz; Jeffrey A Hubbell
Journal:  Nat Biomed Eng       Date:  2020-04-13       Impact factor: 25.671

9.  B cell infection and activation by rabies virus-based vaccines.

Authors:  Andrew G Lytle; James E Norton; Corin L Dorfmeier; Shixue Shen; James P McGettigan
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

10.  Cytomegalovirus-specific responses of CD38⁺ memory T cells are skewed towards IFN-γ and dissociated from CD154 in HIV-1 infection.

Authors:  Gustavo Olvera-García; Enrique Espinosa; Scott F Sieg; Michael M Lederman
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.